Effectiveness of Prophylactic Use of Hepatoprotectants for Tuberculosis Drug-Induced Liver Injury: A Population-Based Cohort Analysis Involving 6,743 Chinese Patients.

Chen, Qin; Hu, Airong; Ma, Aixia; Jiang, Feng; Xiao, Yue; Chen, Yanfei; Huang, Ruijian; Yang, Tianchi; Zhou, Jifang

Chen, Qin; Hu, Airong; Ma, Aixia; Jiang, Feng; Xiao, Yue; Chen, Yanfei; Huang, Ruijian; Yang, Tianchi; Zhou, Jifang.

Afiliação

Chen Q; Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Hu A; Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, China.
Ma A; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Jiang F; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Xiao Y; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Chen Y; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Huang R; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.
Yang T; Institute of Tuberculosis Prevention and Control, Ningbo Municipal Center for Disease Control and Prevention, Ningbo, China.
Zhou J; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.

Front Pharmacol ; 13: 813682, 2022.

Article em En | MEDLINE | ID: mdl-35517815

Palavras-chave

drug-induced liver injury; high-dimensional propensity score; pharmacotherapy; prophylaxis; tuberculosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google